These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 6445604

  • 1. Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs.
    McCollum CN, Crow MJ, Rajah SM, Kester RC.
    Surgery; 1980 Jun; 87(6):668-76. PubMed ID: 6445604
    [Abstract] [Full Text] [Related]

  • 2. The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs.
    Kester RC.
    Ann R Coll Surg Engl; 1984 Jul; 66(4):241-6. PubMed ID: 6234841
    [Abstract] [Full Text] [Related]

  • 3. Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man.
    Goldman MD, Simpson D, Hawker RJ, Norcott HC, McCollum CN.
    Ann Surg; 1983 Dec; 198(6):713-6. PubMed ID: 6227296
    [Abstract] [Full Text] [Related]

  • 4. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
    Baumgartner HR.
    Haemostasis; 1979 Dec; 8(3-5):340-52. PubMed ID: 511014
    [Abstract] [Full Text] [Related]

  • 5. Platelet inhibitory drugs: an in vivo method of evaluation in patients.
    Norcott HC, Goldman M, Hawker RJ, Rafiqi EI, Drolc Z, McCollum CN.
    Thromb Haemost; 1982 Dec 27; 48(3):307-10. PubMed ID: 6761890
    [Abstract] [Full Text] [Related]

  • 6. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
    Lorenz R, Siess W, Weber PC.
    Eur J Pharmacol; 1981 Apr 09; 70(4):511-8. PubMed ID: 7238575
    [Abstract] [Full Text] [Related]

  • 7. Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole.
    Oblath RW, Buckley FO, Green RM, Schwartz SI, DeWeese JA.
    Surgery; 1978 Jul 09; 84(1):37-44. PubMed ID: 149385
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
    Arfors KE, Bergqvist D, Tangen O.
    Acta Chir Scand; 1975 Jul 09; 141(1):40-2. PubMed ID: 1092111
    [Abstract] [Full Text] [Related]

  • 10. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
    Hanson SR, Harker LA, Bjornsson TD.
    J Clin Invest; 1985 May 09; 75(5):1591-9. PubMed ID: 3923041
    [Abstract] [Full Text] [Related]

  • 11. Prevention of platelet deposition and thrombus formation on hemodialysis membranes: a double-blind randomized trial of aspirin and dipyridamole.
    Salter MC, Crow MJ, Donaldson DR, Roberts TG, Rajah SM, Davison AM.
    Artif Organs; 1984 Feb 09; 8(1):57-61. PubMed ID: 6703927
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
    Cadroy Y, Thalamas C, Sakariassen K, Boneu B.
    Thromb Res; 2005 Feb 09; 116(4):293-300. PubMed ID: 16038713
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O.
    Schweiz Med Wochenschr; 1979 Mar 10; 109(10):348-53. PubMed ID: 424707
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled platelets. Effect of dipyridamole and aspirin.
    Pumphrey CW, Chesebro JH, Dewanjee MK, Wahner HW, Hollier LH, Pairolero PC, Fuster V.
    Am J Cardiol; 1983 Mar 01; 51(5):796-801. PubMed ID: 6219569
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G, Segalés E, Salas E, Badimon L.
    Circulation; 2004 Sep 21; 110(12):1686-93. PubMed ID: 15381660
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.